To impose a 50 percent rate of duty on hemp products imported from China and establish mandatory testing requirements for all imports of certain cannabinoid products, and for other purposes.

HR10929, introduced by Rep. Val T. Hoyle (D-OR-4) on October 29, 2026, would impose a 50% duty on hemp products imported from China and establish mandatory testing requirements for all imports of certain cannabinoid products. The bill has been referred to the House Committee on Ways and Means, which has jurisdiction over tariffs and trade. As of the analysis date, the bill has no cosponsors, indicating limited initial support. The legislative path forward includes committee markup, potential amendments, floor votes in both chambers, and presidential action. Given the early stage and lack of bipartisan backing, passage is uncertain. The bill does not authorize or appropriate any funding; it operates through tariff imposition and regulatory testing requirements. Structurally, the tariff would benefit domestic hemp producers by making Chinese imports more expensive, while the testing mandate would increase compliance costs for importers of cannabinoid products. However, specific publicly traded companies with clear exposure to this bill are not identifiable from the provided data. The bill's impact on financial markets is currently minimal due to its procedural status.